CR9616A - NEW INJECTABLE COMPOSITIONS AND PROCEDURE FOR THE PREPARATION OF SUCH COMPOSITIONS - Google Patents

NEW INJECTABLE COMPOSITIONS AND PROCEDURE FOR THE PREPARATION OF SUCH COMPOSITIONS

Info

Publication number
CR9616A
CR9616A CR9616A CR9616A CR9616A CR 9616 A CR9616 A CR 9616A CR 9616 A CR9616 A CR 9616A CR 9616 A CR9616 A CR 9616A CR 9616 A CR9616 A CR 9616A
Authority
CR
Costa Rica
Prior art keywords
compositions
procedure
preparation
cox
new injectable
Prior art date
Application number
CR9616A
Other languages
Spanish (es)
Inventor
Jain Rajesh
Chand Jindai Kour
Singh Sukhjeet
Boldhane Sanjay
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of CR9616A publication Critical patent/CR9616A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan composiciones farmaceuticas inyectables altamente estables y novedosas que comprenden por lo menos un inhibidor de enzima ciclooxigenasa II (COX II) o farmaco anti-inflamatorio no esteroidal (NSAID) o inhibidor de COX/LOX, o sus formas tautomericas, analogos, isomeros, polimorfos, solvatos, profarmacos o sales de los mismos como ingrediente activo adecuado para administracion parenteral preferiblemente por via intramuscular (IM) o intravenosa (IV); procedimiento para preparar dichas composiciones y metodos terapeuticos para utilizar dichas composiciones.Highly stable and novel injectable pharmaceutical compositions are provided comprising at least one cyclooxygenase II enzyme inhibitor (COX II) or non-steroidal anti-inflammatory drug (NSAID) or COX / LOX inhibitor, or its tautomeric, analog, isomeric forms. polymorphs, solvates, prodrugs or salts thereof as an active ingredient suitable for parenteral administration preferably intramuscularly (IM) or intravenously (IV); process for preparing said compositions and therapeutic methods for using said compositions.

CR9616A 2005-05-27 2007-12-19 NEW INJECTABLE COMPOSITIONS AND PROCEDURE FOR THE PREPARATION OF SUCH COMPOSITIONS CR9616A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1357DE2005 2005-05-27

Publications (1)

Publication Number Publication Date
CR9616A true CR9616A (en) 2008-10-30

Family

ID=36917368

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9616A CR9616A (en) 2005-05-27 2007-12-19 NEW INJECTABLE COMPOSITIONS AND PROCEDURE FOR THE PREPARATION OF SUCH COMPOSITIONS

Country Status (15)

Country Link
EP (1) EP1895983A2 (en)
JP (1) JP2008542260A (en)
KR (1) KR20080016689A (en)
CN (1) CN101217939A (en)
AU (1) AU2006250765A1 (en)
BR (1) BRPI0611170A2 (en)
CA (1) CA2609242A1 (en)
CR (1) CR9616A (en)
EA (1) EA200702646A1 (en)
MX (1) MX2007014862A (en)
NO (1) NO20076468L (en)
RS (1) RS20070461A (en)
TN (1) TNSN07482A1 (en)
WO (1) WO2006126214A2 (en)
ZA (1) ZA200711068B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2562669T3 (en) * 2007-09-07 2016-03-07 United Therapeutics Corporation Buffer solutions with a selective bactericidal activity against Gram negative bacteria and methods to use them
BRPI1006222A2 (en) 2009-03-12 2016-08-02 Cumberland Pharmaceuticas Inc use of ibuprofen to reduce pain in human patients undergoing surgery, use of ibuprofen to reduce surgical pain in human patients and use of ibuprofen to improve outpatient time after operation in human patients who undergo orthopedic surgical procedures
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
CN102335114B (en) * 2010-07-23 2015-07-15 重庆医药工业研究院有限责任公司 Stable ibuprofen arginine injection and preparation method thereof
CN102370615B (en) * 2010-08-19 2013-09-04 四川科伦药物研究有限公司 Ibuprofen injection preparation and preparation method thereof
WO2013058303A1 (en) 2011-10-18 2013-04-25 ラクオリア創薬株式会社 Medicinal composition
CN102512383A (en) * 2011-12-25 2012-06-27 天津市嵩锐医药科技有限公司 Parecoxib sodium pharmaceutical composition for injection
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN103372216B (en) * 2012-04-26 2015-05-06 北京京卫燕康药物研究所有限公司 Solid medical composition containing celecoxib
TWI646091B (en) 2012-12-28 2019-01-01 日商衛斯克慧特股份有限公司 Salt and crystal form
US20140187635A1 (en) * 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
CN103263385B (en) * 2013-05-17 2016-04-27 江苏正大清江制药有限公司 A kind of celecoxib long-acing nano injection and preparation method thereof
AU2015365533A1 (en) * 2014-12-20 2017-07-06 Troikaa Pharmaceuticals Limited Injectable formulations of paracetamol
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
CN107303266B (en) * 2016-04-18 2020-09-08 重庆润泽医药有限公司 Levo-oxiracetam injection and preparation method thereof
CN107303264A (en) * 2016-04-18 2017-10-31 重庆润泽医药有限公司 Non-foam levo-oxiracetam parenteral solution and preparation method thereof
FR3077984B1 (en) * 2018-02-16 2020-02-21 Vetoquinol Sa MULTI-PURPOSE COMPOSITION OF TORASEMIDE
CN109498852B (en) * 2018-12-29 2022-06-24 广州噢斯荣医药技术有限公司 Biodegradable material for treating orthopedic diseases and application thereof
CN111103381A (en) * 2019-12-25 2020-05-05 南京希麦迪医药科技有限公司 Method for determining nimesulide concentration in human plasma by liquid chromatography-mass spectrometry

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IT1283252B1 (en) * 1996-03-15 1998-04-16 Pulitzer Italiana SOLUTIONS OF PIROXICAM INJECTABLE BY PARENTERAL WAY
IN187306B (en) * 1998-01-12 2002-03-23 Panacea Biotec Ltd
US7695736B2 (en) * 2001-04-03 2010-04-13 Pfizer Inc. Reconstitutable parenteral composition
AU2003249510A1 (en) * 2002-08-12 2004-02-25 Ranbaxy Laboratories Limited A parenteral dosage form of selective cox-2 inhibitors

Also Published As

Publication number Publication date
JP2008542260A (en) 2008-11-27
AU2006250765A1 (en) 2006-11-30
WO2006126214A3 (en) 2007-06-07
CN101217939A (en) 2008-07-09
ZA200711068B (en) 2009-03-25
BRPI0611170A2 (en) 2010-08-17
MX2007014862A (en) 2008-02-21
RS20070461A (en) 2008-11-28
TNSN07482A1 (en) 2009-03-17
WO2006126214A2 (en) 2006-11-30
CA2609242A1 (en) 2006-11-30
EA200702646A1 (en) 2008-06-30
EP1895983A2 (en) 2008-03-12
KR20080016689A (en) 2008-02-21
NO20076468L (en) 2008-02-27

Similar Documents

Publication Publication Date Title
CR9616A (en) NEW INJECTABLE COMPOSITIONS AND PROCEDURE FOR THE PREPARATION OF SUCH COMPOSITIONS
CL2009001059A1 (en) Compounds derived from substituted 1,3-oxazin-2-one-3.6, inhibitors of the activity of 11-beta-hydroxysteroid dehydrogenase i; pharmaceutical composition that includes them; Useful in the treatment of diseases such as diabetes mellitus, among others.
CR10148A (en) DERIVATIVES OF BENZAMIDS AND HETEROARANS
UY30977A1 (en) DERIVATIVES OF ISOINDOLINAS 4 '-O-REPLACED. COMPOSITIONS THAT CONTAIN THEM AND METHODS FOR THEIR USES.
CR10573A (en) DERIVATIVES OF PIRAZOL AS INHIBITORS OF CITOCROMO P450
GT200900283A (en) "COMBINATION THERAPY WITH A COMPOUND ACTING AS AN ADP PLAQUETARY RECEPTOR INHIBITOR".
CR11518A (en) CARBAMOIL COMPOUNDS AS DGAT1 190 INHIBITORS
DOP2011000176A (en) ORGANIC COMPOUNDS
AR062875A1 (en) N-METHYLAMINOMETIL ISOINDOL COMPOUNDS AND COMPOSITIONS THAT INCLUDE THEM AND METHODS TO USE THEM
DOP2006000193A (en) ISOINDOL-IMIDA COMPOUNDS AND COMPOSITIONS INCLUDING THEM AND METHODS FOR USE
CL2008000946A1 (en) COMPOUNDS DERIVED FROM PIRROLOPIRIMIDINA, INHIBITORS OF CIANASA JAK3; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF REPLACEMENT OF TRANSPLANTS, AUTOIMMUN DISEASES
NI200900093A (en) COMPOUNDS THAT MODULATE THE ACTIVITY OF C-FMS AND / OR C-KIT AND USE OF THE SAME.
CR11819A (en) 5-SUBSTITUTED ISOINDOLINE COMPOUNDS
CR9667A (en) BENZAMIDA DERIVATIVES AND USES RELATED TO THE SAME
NI200900040A (en) 5-SUBSTITUTE QUINAZOLINONE DERIVATIVES AS ANTITUMORAL AGENTS.
UY32793A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS AND ITS USES
CL2008003284A1 (en) Compounds derived from 4-benzylamino-1-carboxyacyl-pyridine, cetp inhibitors; pharmaceutical composition comprising them; pharmaceutical combination; and use in the treatment of metabolic, atherosclerosis and cardiovascular diseases, among others.
ECSP088296A (en) THERAPEUTIC COMPOUNDS
CL2015002608A1 (en) Amino-pyrazole compound and related medicinal uses.
UY33075A (en) CYCLHEXAN DERIVATIVES AND USES OF THE SAME
PA8623101A1 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS
UY32315A (en) PIPERIDINE COMPOUNDS AND USES OF THE SAME-596
CR8270A (en) TETRAZOL DERIVATIVES AND METHODS FOR TREATMENT WITH THE SAME DISORDERS RELATED TO METABOLISM
GT200600366A (en) IMIDAZOL COMPOUNDS REPLACED AS KSP INHIBITORS
CL2009000281A1 (en) Compounds derived from 5,6-dihydro-pyrrolo- [2,1-a] -isoquinolines and pyrrolo- [2,1-a] -isoquinolines; pharmaceutical composition comprising said compounds; and use for the treatment of fertility disorders.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)